The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Accuray, Inc. | Common | 004397105 | 5,409 | 731,943 | SH | SOLE | 731,943 | 0 | 0 | ||
Acorda Therapeutics, Inc. | Common | 00484M106 | 3,870 | 112,881 | SH | SOLE | 112,881 | 0 | 0 | ||
Actavis, Inc. | Common | 00507K103 | 13,176 | 91,500 | SH | SOLE | 91,500 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Common | 00767E102 | 1,018 | 11,880 | SH | SOLE | 11,880 | 0 | 0 | ||
Aetna, Inc. | Common | 00817Y108 | 15,803 | 246,841 | SH | SOLE | 246,841 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 18,416 | 935,758 | SH | SOLE | 935,758 | 0 | 0 | ||
Alere, Inc. | Common | 01449J105 | 11,297 | 369,553 | SH | SOLE | 369,553 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 43,134 | 371,329 | SH | SOLE | 371,329 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 6,552 | 194,870 | SH | SOLE | 194,870 | 0 | 0 | ||
Allergan, Inc. | Common | 018490102 | 15,067 | 166,577 | SH | SOLE | 166,577 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 1,520 | 23,745 | SH | SOLE | 23,745 | 0 | 0 | ||
Amarin Corporation plc | Sponsored ADR | 023111206 | 8,796 | 1,391,723 | SH | SOLE | 1,391,723 | 0 | 0 | ||
Amgen, Inc. | Common | 031162100 | 46,135 | 412,143 | SH | SOLE | 412,143 | 0 | 0 | ||
ARIAD Pharmaceuticals, Inc. | Common | 04033A100 | 7,599 | 412,965 | SH | SOLE | 412,965 | 0 | 0 | ||
Auxilium Pharmaceuticals, Inc. | Common | 05334D107 | 4,558 | 250,020 | SH | SOLE | 250,020 | 0 | 0 | ||
Avanir Pharmaceuticals, Inc. | Common | 05348P401 | 4,070 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
Baxter International, Inc. | Common | 071813109 | 5,102 | 77,675 | SH | SOLE | 77,675 | 0 | 0 | ||
Biogen Idec, Inc. | Common | 09062X103 | 46,222 | 191,983 | SH | SOLE | 191,983 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 13,135 | 181,870 | SH | SOLE | 181,870 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 78,511 | 510,046 | SH | SOLE | 510,046 | 0 | 0 | ||
Ceres, Inc. | Common | 156773103 | 426 | 285,981 | SH | SOLE | 285,981 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 1,379 | 22,687 | SH | SOLE | 22,687 | 0 | 0 | ||
Cubist Pharmaceuticals, Inc. | Common | 229678107 | 14,411 | 226,772 | SH | SOLE | 226,772 | 0 | 0 | ||
CVS Caremark Corporation | Common | 126650100 | 3,047 | 53,694 | SH | SOLE | 53,694 | 0 | 0 | ||
Elan Corporation plc | ADR | 284131208 | 3,778 | 242,500 | SH | SOLE | 242,500 | 0 | 0 | ||
Endo Pharmaceuticals Holdings, Inc. | Common | 29264F205 | 5,735 | 126,215 | SH | SOLE | 126,215 | 0 | 0 | ||
Forest Laboratories, Inc. | Common | 345838106 | 6,269 | 146,500 | SH | SOLE | 146,500 | 0 | 0 | ||
Gentium S.p.A. | ADR | 37250B104 | 1,751 | 64,543 | SH | SOLE | 64,543 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 94,556 | 1,504,712 | SH | SOLE | 1,504,712 | 0 | 0 | ||
Hologic, Inc. | Common | 436440101 | 12,244 | 592,915 | SH | SOLE | 592,915 | 0 | 0 | ||
iCAD, Inc. | Common | 44934S206 | 467 | 88,527 | SH | SOLE | 88,527 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 5,607 | 56,265 | SH | SOLE | 56,265 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 8,393 | 103,841 | SH | SOLE | 103,841 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 7,069 | 344,683 | SH | SOLE | 344,683 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 16,073 | 421,300 | SH | SOLE | 421,300 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | Common | 45665G303 | 6,106 | 349,899 | SH | SOLE | 349,899 | 0 | 0 | ||
IntelliPharmaCeutics International, Inc. | Common | 458173101 | 3,401 | 1,735,000 | SH | SOLE | 1,735,000 | 0 | 0 | ||
Ironwood Pharmaceuticals, Inc. | Common | 46333X108 | 9,101 | 768,050 | SH | SOLE | 768,050 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | ETF | 464287556 | 17,594 | 83,940 | SH | SOLE | 83,940 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 7,295 | 56,862 | SH | SOLE | 56,862 | 0 | 0 | ||
Medivation, Inc. | Common | 58501N101 | 5,526 | 92,200 | SH | SOLE | 92,200 | 0 | 0 | ||
MEI Pharma, Inc. | Common | 55279B202 | 2,766 | 243,920 | SH | SOLE | 243,920 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 14,122 | 296,620 | SH | SOLE | 296,620 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 3,836 | 1,009,400 | SH | SOLE | 1,009,400 | 0 | 0 | ||
Mylan, Inc. | Common | 628530107 | 18,635 | 488,209 | SH | SOLE | 488,209 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 6,457 | 570,387 | SH | SOLE | 570,387 | 0 | 0 | ||
NPS Pharmaceuticals, Inc. | Common | 62936P103 | 1,936 | 60,860 | SH | SOLE | 60,860 | 0 | 0 | ||
OncoGenex Pharmaceuticals, Inc. | Common | 68230A106 | 1,048 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
Onyx Pharmaceuticals, Inc. | Common | 683399109 | 15,489 | 124,238 | SH | SOLE | 124,238 | 0 | 0 | ||
Perrigo Company | Common | 714290103 | 24,998 | 202,607 | SH | SOLE | 202,607 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 24,620 | 458,816 | SH | SOLE | 458,816 | 0 | 0 | ||
Questcor Pharmaceuticals, Inc. | Common | 74835Y101 | 9,415 | 162,328 | SH | SOLE | 162,328 | 0 | 0 | ||
Raptor Pharmaceutical Corp. | Common | 75382F106 | 1,643 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 81,565 | 260,699 | SH | SOLE | 260,699 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 5,509 | 270,031 | SH | SOLE | 270,031 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 18,481 | 154,153 | SH | SOLE | 154,153 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Common | 868459108 | 1,032 | 140,800 | SH | SOLE | 140,800 | 0 | 0 | ||
Synta Pharmaceuticals Corp. | Common | 87162T206 | 3,090 | 489,750 | SH | SOLE | 489,750 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 13,392 | 354,476 | SH | SOLE | 354,476 | 0 | 0 | ||
UnitedHealth Group, Inc. | Common | 91324P102 | 5,903 | 82,436 | SH | SOLE | 82,436 | 0 | 0 | ||
Verastem, Inc. | Common | 92337C104 | 11,008 | 884,920 | SH | SOLE | 884,920 | 0 | 0 | ||
Vertex Pharmaceuticals, Inc. | Common | 92532F100 | 37,892 | 499,764 | SH | SOLE | 499,764 | 0 | 0 | ||
Warner Chilcott plc | Shares A | G94368100 | 16,310 | 713,797 | SH | SOLE | 713,797 | 0 | 0 |